Cytyc, Xoft settles brachytherapy IP row:
This article was originally published in Clinica
Cytyc, the Marlborough, Massachusetts-based specialist in women's health and cancer diagnostics, has resolved an intellectual property dispute with radiotherapy company Xoft concerning balloon-based brachytherapy technologies developed by both firms to treat breast cancer patients. The settlement will see Fremont, California-based Xoft pay Cytyc royalties of an undisclosed sum, for which the former will gain the freedom to continue selling its Axxent electronic brachytherapy system. The two companies have also agreed to discuss potential opportunities to co-develop technologies in several areas, including women's health.